{
    "title": "AstraZeneca says its COVID shot has market potential despite lower demand",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10766857/AstraZeneca-says-COVID-shot-market-potential-despite-lower-demand.html",
    "date": "2022-04-29",
    "keywords": [
        "vaccine",
        "astrazeneca",
        "approval",
        "soriot",
        "covid19",
        "market",
        "year",
        "profit",
        "use",
        "countrys",
        "oversupply",
        "executive",
        "friday",
        "quarter",
        "focus",
        "protection",
        "disease",
        "astrazenecas",
        "shot",
        "university",
        "durability",
        "volume",
        "future",
        "booster",
        "everybody",
        "move",
        "atcost",
        "drugmaker",
        "basis",
        "union",
        "britain",
        "decision",
        "conclusion",
        "result",
        "pfizer",
        "health",
        "rebuke",
        "information",
        "reporting",
        "pushkala",
        "aripaka",
        "bengaluru",
        "grover",
        "editing",
        "alexander",
        "smithh"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}